Efficacy and CNS Toxicity of Nivolumab and Ipilimumab in Rare Cancer Brain Metastases: A Multicenter Basket Trial Analysis (NCI/SWOG S1609)

20250 citationsJournal Articlehybrid Open Access

Authors

Dual-ICI therapy showed comparable efficacy and safety in patients with and without BM.

Published in: Clinical Cancer Research

Field-Weighted Citation Impact: 0.00